Laboratory Corp. Of America Holdings

LH

$218.41

-20.1% last 12 months

Steven Cohen Holding value: $45.5 Million Daniel Loeb Holding value: $42 Million Jeremy Grantham Holding value: $41.2 Million Ken Griffin Holding value: $38.6 Million Jim Simons Holding value: $31.7 Million Ray Dalio Holding value: $30.6 Million Joel Greenblatt Holding value: $3.83 Million Ken Fisher Holding value: $294 Thousand Gabe Plotkin Holding value: $0 Mario Gabelli Holding value: $0 Tom Gayner Holding value: $0 Tom Russo Holding value: $0 Chris Davis Holding value: $0 George Soros Holding value: $0 Glenn Greenberg Holding value: $0

Market Cap

$19 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$199.15 - $277.50

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

14.85x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$2.87 (1.34%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $19 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $24 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $2.87 (1.34%)
1 Year Return Profit or loss of share price change plus dividend yield. -18.7%
52-Week High Highest share price in the last 52 weeks. $277.50
52-Week Low Lowest share price in the last 52 weeks. $199.15
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.77
Outstanding Shares The number of shares the company has issued and are held by stockholders. 88.5 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 633 Thousand

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 14.85
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -17.22
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $13.96
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 1.3
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 1.92
Enterprise Value to Revenue Enterprise value divided by revenue 1.61
Enterprise Value to EBIT Enterprise Value divided by EBIT 11.24
Total Debt to Enterprise Value Total debt divided by enterprise value 0.23
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.54

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $14.9 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $4.39 Billion
EBIT Earnings before tax and interest payments. $2.13 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $1.28 Billion
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 8.60%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -86.2%
Return on Equity Equity divided by market cap. 12.67%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.35%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 12.50%

Insider trades

42.0 shares bought (1 transactions)

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q2 2022 Q3 2022 Q4 2022 Q1 2023

About Laboratory Corp. Of America Holdings

CEO: David King

Industry: Dental Laboratories

Similar stocks

Quest Diagnostics, Inc.
Quest Diagnostics, Inc.
Neogenomics Inc.
Neogenomics Inc.
Enzo Biochem, Inc.
Enzo Biochem, Inc.
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Qiagen NV
Qiagen NV
Telesis Bio Inc
Telesis Bio Inc

News

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday''s Mid-Day Session

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday''s Mid-Day Session

Gainers Enzo Biochem, Inc. (NYSE: ENZ ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. Histogen Inc. (NAS...

Benzinga Benzinga, 9 days ago
Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp

Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp

Enzo Biochem (ENZ) on Thursday said it has sold its Clinical Laboratory division to Labcorp (LH).Financial details of the transaction were not disclosed.

Seeking Alpha Seeking Alpha, 9 days ago
Laboratory Corporation of America PT Lowered to $288 at Credit Suisse

Laboratory Corporation of America PT Lowered to $288 at Credit Suisse

https://www.investing.com/news/pro/laboratory-corporation-of-america-pt-lowered-to-288-at-credit-suisse-432SI-3028539

Investing.com Investing.com, 13 days ago
Analysts Offer Predictions for Laboratory Co. of America Holdings'' FY2022 Earnings

Analysts Offer Predictions for Laboratory Co. of America Holdings'' FY2022 Earnings

Laboratory Co. of America Holdings - Stock analysts at Jefferies Financial Group dropped their FY2022 earnings per share estimates for Laboratory Co. of Amer...

Business Mag Business Mag, about 1 month ago
Never miss a trade
To improve your user experience we use cookies.